SPCE vs SRTA: stock comparison and AI forecast
Virgin Galactic Holdings, Inc (SPCE) and Strata Critical Medical, Inc. (SRTA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
SPCE Virgin Galactic Holdings, Inc
- Market Cap
- $374M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SRTA Strata Critical Medical, Inc.
- Market Cap
- $379M
- P/E Ratio
- 10.0x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- SPCE and SRTA have similar market capitalizations ($374M and $379M).
- SRTA turns 19.0% of its revenue into net income, against -23867.4% for SPCE.
- SPCE carries 1.06 times debt per unit of equity, against 0.19 times for SRTA.
- Both companies share the SEC industry classification Transportation Services.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | SPCE | SRTA |
|---|---|---|
| Market Cap | $374M | $379M |
| P/E Ratio | – | 9.95x |
| P/B Ratio | 0.95x | 1.36x |
| EPS | $-2.09 | $0.43 |
| Book Value/Share | $2.61 | $3.16 |
| Revenue/Share | $0.01 | $2.40 |
| FCF/Share | $-2.55 | $-0.55 |
Profitability & Margins
| Metric | SPCE | SRTA |
|---|---|---|
| ROE | -62.5% | 14.4% |
| ROA | -30.4% | 12.1% |
| ROIC | -41.3% | -6.3% |
| Gross Margin | -9106.1% | 19.2% |
| Operating Margin | -24804.5% | -8.6% |
| Net Margin | -23867.4% | 19.0% |
| EBT Margin | -23857.7% | -9.9% |
| Tax Rate | -0.0% | 0.0% |
Financial Health
| Metric | SPCE | SRTA |
|---|---|---|
| Current Ratio | 1.62x | 2.64x |
| D/E Ratio | 1.06x | 0.19x |
| Financial Leverage | 2.06x | 1.19x |
| Interest Coverage | -64.3x | -4.3x |
| Working Capital | $120M | $75M |
Cash Flow
| Metric | SPCE | SRTA |
|---|---|---|
| Operating Cash Flow | -$212M | -$36M |
| Free Cash Flow | -$386M | -$48M |
| Capital Spending | -$174M | -$12M |
| OCF Growth YoY | – | -2886.7% |
| FCF/Sales | -37231.3% | -22.8% |
| CapEx/Sales | 16764.0% | 5.8% |
Operational Efficiency
| Metric | SPCE | SRTA |
|---|---|---|
| Asset Turnover | 0.00x | 0.64x |
| Receivables Turnover | – | 4.9x |
| Fixed Assets Turnover | 0.0x | 5.2x |
| Days Sales Outstanding | – | 75 days |
| Payables Period | 79 days | – |
Income Statement
| Metric | SPCE | SRTA |
|---|---|---|
| Total Revenue | $1M | $212M |
| Operating Income | -$257M | -$18M |
| Net Income | -$248M | $40M |
| R&D Expense | $38M | $3M |
| SG&A Expense | $109M | $22M |
| Cost of Goods Sold | $96M | $171M |
Dividend & Shareholder Information
| Metric | SPCE | SRTA |
|---|---|---|
| Shares Outstanding | 152M | 88M |
SPCE vs SRTA: stock comparison and AI forecast
Which is bigger, SPCE or SRTA?
SPCE and SRTA have similar market capitalizations ($374M and $379M).
Which one does Intratio's AI model rank higher, SPCE or SRTA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.